Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice:a population database study

Effects of Angiotensin Converting Angiotensin Receptor Blockade Nationwide Data Survey and

Yi-chih Wang

August 2016

Abstract: Long-term benefit of using a renin–angiotensin–aldoster-one system blocker such as an angi...

Appropriateness of Repeated Clinical Alerts to Add Angiotensin Converting Enzyme Inhibitor Therapy in Diabetic Patients with Medicare Part D Coverage

Hryshko, Patrick
Johnson, Zac
Scovis, Nicki

January 2014

Class of 2014 AbstractSpecific Aims: To identify reasons that an angiotensin converting enzyme inhib...

ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes

Morris, Andrew D.
Boyle, Douglas I.R.
Mcmahon, Alexander D.
Pearce, Hilary
Evans, Josie M.M.
Newton, Ray W.
Jung, Roland T.
Macdonald, Thomas M.

September 1997

OBJECTIVE - To evaluate the association between the use of ACE inhibitors and hospital admission for...

Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice:a population database study

Mathieson, L
Severn, A
Guthrie, B

May 2013

To determine whether angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB)...

Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors

Mahmoudpour, Seyed Hamidreza
Asselbergs, Folkert
Keyser, Catherina Elisabeth
Souverein, Patrick
Hofman, Albert
Stricker, Bruno
Boer, Anton
Maitland-van der Zee, Anke-Hilse

December 2015

Background Angiotensin converting enzyme inhibitors (ACEIs) are among the most frequently prescribed...

Underuse of ACE inhibitors and angiotensin II receptor blockers among patients with diabetic nephropathy in Taiwan

Yeh, Hseng-Long
Huang, Li-Ying
Su, Syi
Yang, Ming-Chin
Wang, Ting-Chung

Objectives National guidelines recommend angiotensin-converting enzyme inhibitors (ACEIs) or angiote...

Discontinuation of angiotensin converting enzyme inhibitors (ACEIs) as a potential marker for adverse drug reactions (ADRs)

Pour, Seyed Hamidreza Mahmoud
De Keyser, Catherine E.
Souverein, Patrick C.
Asselbergs, Folkert W.
Hofman, Albert
Stricker, Bruno H.
De Boer, Anthonius
Maitland-Van Der Zee, Anke-Hilse
Dep Farmaceutische wetenschappen
Sub Pharmacotherapy, Theoretical
Sub Gen. Pharmacoepi and Clinical Pharm
Sub Pharmacoepidemiology
Pharmacoepidemiology
Pharmacoepidemiology and Clinical Pharmacology

October 2014

Background: ACEI-induced ADRs are the main reason to discontinue ACEI treatment. In prescription dat...

Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension : a study of 15 990 patients

Hasvold, L. P.
Bodegard, J.
Thuresson, M.
Stålhammar, Jan
Hammar, N.
Sundström, Johan
Russell, D.
Kjeldsen, S. E.

January 2014

Differences in clinical effectiveness between angiotensin-converting enzyme inhibitors (ACEis) and a...

Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient

Ghassan Jarred
R. Lee Kennedy

April 2010

There are extensive data confirming involvement of the renin-angiotensin system in microvascular and...

Adverse drug reactions of angiotensin converting enzyme inhibitors : towards precision medicine

Mahmoud Pour, S.H.

June 2016

Worldwide, millions of patients with cardiovascular diseases are treated with angiotensin converting...

Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient

Jarred, Ghassan
Kennedy, R. Lee

April 2010

There are extensive data confirming involvement of the renin-angiotensin system in microvascular and...

Utilization of angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) in patients diagnosed with diabetes: Analysis from the National Ambulatory Medical Care Survey

Ibrahim, Sarai L.
Jiroutek, Michael R.
Holland, Melissa A.
Sutton, Beth S.

June 2016

AbstractObjectiveThe objective of this study was to determine if a difference exists in the proporti...

Underuse of Ace Inhibitors and Angiotensin Ii Receptor Blockers among Patients with Diabetic Nephropathy in Taiwan

葉勳龍
YEH, HSENG-LONG

June 2012

Objectives: National guidelines recommend angiotensin- converting enzyme inhibitors (ACE15) or angio...

Comparing the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on renal function decline in diabetes

Huang, Yunyu
Haaijer-Ruskamp, Flora M.
Voorham, Jaco

May 2016

Aim: To compare effectiveness of angiotensin-converting enzyme inhibitors (ACEis)/angiotensin recept...

Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and the risk of major adverse cardiac events in patients with diabetes and prior stroke: A nationwide study

Shih, CJ

[[abstract]]OBJECTIVE: Renin-angiotensin-aldosterone system blockers are the preferred antihypertens...

Effects of Angiotensin Converting Angiotensin Receptor Blockade Nationwide Data Survey and

Yi-chih Wang

August 2016

Abstract: Long-term benefit of using a renin–angiotensin–aldoster-one system blocker such as an angi...

Appropriateness of Repeated Clinical Alerts to Add Angiotensin Converting Enzyme Inhibitor Therapy in Diabetic Patients with Medicare Part D Coverage

Hryshko, Patrick
Johnson, Zac
Scovis, Nicki

January 2014

Class of 2014 AbstractSpecific Aims: To identify reasons that an angiotensin converting enzyme inhib...

ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes

Morris, Andrew D.
Boyle, Douglas I.R.
Mcmahon, Alexander D.
Pearce, Hilary
Evans, Josie M.M.
Newton, Ray W.
Jung, Roland T.
Macdonald, Thomas M.

September 1997

OBJECTIVE - To evaluate the association between the use of ACE inhibitors and hospital admission for...

Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice:a population database study

Mathieson, L
Severn, A
Guthrie, B

May 2013

To determine whether angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB)...

Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors

Mahmoudpour, Seyed Hamidreza
Asselbergs, Folkert
Keyser, Catherina Elisabeth
Souverein, Patrick
Hofman, Albert
Stricker, Bruno
Boer, Anton
Maitland-van der Zee, Anke-Hilse

December 2015

Background Angiotensin converting enzyme inhibitors (ACEIs) are among the most frequently prescribed...

Underuse of ACE inhibitors and angiotensin II receptor blockers among patients with diabetic nephropathy in Taiwan

Yeh, Hseng-Long
Huang, Li-Ying
Su, Syi
Yang, Ming-Chin
Wang, Ting-Chung

Objectives National guidelines recommend angiotensin-converting enzyme inhibitors (ACEIs) or angiote...

Discontinuation of angiotensin converting enzyme inhibitors (ACEIs) as a potential marker for adverse drug reactions (ADRs)

Pour, Seyed Hamidreza Mahmoud
De Keyser, Catherine E.
Souverein, Patrick C.
Asselbergs, Folkert W.
Hofman, Albert
Stricker, Bruno H.
De Boer, Anthonius
Maitland-Van Der Zee, Anke-Hilse
Dep Farmaceutische wetenschappen
Sub Pharmacotherapy, Theoretical
Sub Gen. Pharmacoepi and Clinical Pharm
Sub Pharmacoepidemiology
Pharmacoepidemiology
Pharmacoepidemiology and Clinical Pharmacology

October 2014

Background: ACEI-induced ADRs are the main reason to discontinue ACEI treatment. In prescription dat...

Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension : a study of 15 990 patients

Hasvold, L. P.
Bodegard, J.
Thuresson, M.
Stålhammar, Jan
Hammar, N.
Sundström, Johan
Russell, D.
Kjeldsen, S. E.

January 2014

Differences in clinical effectiveness between angiotensin-converting enzyme inhibitors (ACEis) and a...

Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient

Ghassan Jarred
R. Lee Kennedy

April 2010

There are extensive data confirming involvement of the renin-angiotensin system in microvascular and...

Adverse drug reactions of angiotensin converting enzyme inhibitors : towards precision medicine

Mahmoud Pour, S.H.

June 2016

Worldwide, millions of patients with cardiovascular diseases are treated with angiotensin converting...

Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient

Jarred, Ghassan
Kennedy, R. Lee

April 2010

There are extensive data confirming involvement of the renin-angiotensin system in microvascular and...

Utilization of angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) in patients diagnosed with diabetes: Analysis from the National Ambulatory Medical Care Survey

Ibrahim, Sarai L.
Jiroutek, Michael R.
Holland, Melissa A.
Sutton, Beth S.

June 2016

AbstractObjectiveThe objective of this study was to determine if a difference exists in the proporti...

Underuse of Ace Inhibitors and Angiotensin Ii Receptor Blockers among Patients with Diabetic Nephropathy in Taiwan

葉勳龍
YEH, HSENG-LONG

June 2012

Objectives: National guidelines recommend angiotensin- converting enzyme inhibitors (ACE15) or angio...

Comparing the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on renal function decline in diabetes

Huang, Yunyu
Haaijer-Ruskamp, Flora M.
Voorham, Jaco

May 2016

Aim: To compare effectiveness of angiotensin-converting enzyme inhibitors (ACEis)/angiotensin recept...

Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and the risk of major adverse cardiac events in patients with diabetes and prior stroke: A nationwide study

Shih, CJ

[[abstract]]OBJECTIVE: Renin-angiotensin-aldosterone system blockers are the preferred antihypertens...

Effects of Angiotensin Converting Angiotensin Receptor Blockade Nationwide Data Survey and

Yi-chih Wang

August 2016

Abstract: Long-term benefit of using a renin–angiotensin–aldoster-one system blocker such as an angi...

Appropriateness of Repeated Clinical Alerts to Add Angiotensin Converting Enzyme Inhibitor Therapy in Diabetic Patients with Medicare Part D Coverage

Hryshko, Patrick
Johnson, Zac
Scovis, Nicki

January 2014

Class of 2014 AbstractSpecific Aims: To identify reasons that an angiotensin converting enzyme inhib...

ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes

Morris, Andrew D.
Boyle, Douglas I.R.
Mcmahon, Alexander D.
Pearce, Hilary
Evans, Josie M.M.
Newton, Ray W.
Jung, Roland T.
Macdonald, Thomas M.

September 1997

OBJECTIVE - To evaluate the association between the use of ACE inhibitors and hospital admission for...

Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice:a population database study

Abstract

Extracted data

Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice:a population database study

Abstract

Extracted data

Related items

Related items